Literature DB >> 23199610

Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.

Patricia G Moorman1, Phyllis Leppert, Evan R Myers, Frances Wang.   

Abstract

OBJECTIVE: To compare pathologic characteristics and epidemiologic risk factors for uterine fibroids in African American and white women undergoing hysterectomy.
DESIGN: Cross-sectional analysis of women undergoing premenopausal hysterectomy.
SETTING: Two university-associated hospitals in North Carolina. PATIENT(S): African American (n = 225) and white women (n = 135) with fibroid diagnosis. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Data were obtained from an in-person interview and abstracted from operative and pathologic reports. Analysis of variance and multiple linear regression models were used to identify characteristics associated with higher uterine weight, greater number of fibroids, and size of the largest fibroid. RESULT(S): African American women had substantially more fibroids (9.9 vs. 4.5) with a concomitant higher mean uterine weight (477 vs. 267 g). Although African American women had a higher prevalence of established risk factors for fibroids, such as high body mass index (BMI) and hypertension, these factors were not associated with larger uteri or more numerous fibroids. In multiple linear regression models, the only factors statistically significantly associated with higher uterine weight, larger fibroids, and more numerous fibroids were race and nulligravidity. CONCLUSION(S): The presentation of fibroids as measured by uterine size or number of fibroids is more severe in African American women compared with white women. The differences in presentation cannot be explained by racial differences in the prevalence of known risk factors. Additional research is needed on environmental and genetic factors that may increase the risk for fibroids.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23199610      PMCID: PMC3632655          DOI: 10.1016/j.fertnstert.2012.10.039

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  33 in total

1.  Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking.

Authors:  E Faerstein; M Szklo; N Rosenshein
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

2.  Risk factors for uterine fibroids among women undergoing tubal sterilization.

Authors:  C R Chen; G M Buck; N G Courey; K M Perez; J Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

3.  Beliefs and perceptions of African American women who have had hysterectomy.

Authors:  Cheryl E Augustus
Journal:  J Transcult Nurs       Date:  2002-10       Impact factor: 1.959

4.  Effect of hysterectomy with ovarian preservation on ovarian function.

Authors:  Patricia G Moorman; Evan R Myers; Joellen M Schildkraut; Edwin S Iversen; Frances Wang; Nicolette Warren
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

5.  Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation.

Authors:  E Faerstein; M Szklo; N B Rosenshein
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

Review 6.  The estimated annual cost of uterine leiomyomata in the United States.

Authors:  Eden R Cardozo; Andrew D Clark; Nicole K Banks; Melinda B Henne; Barbara J Stegmann; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2011-12-11       Impact factor: 8.661

7.  Fibroids in infertility--consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence).

Authors:  Ben Kroon; Neil Johnson; Michael Chapman; Anusch Yazdani; Roger Hart
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-03-22       Impact factor: 2.100

Review 8.  Epidemiologic contributions to understanding the etiology of uterine leiomyomata.

Authors:  S M Schwartz; L M Marshall; D D Baird
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

9.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

10.  The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life.

Authors:  Gaylene Pron; Marsha Cohen; Jennifer Soucie; Greg Garvin; Leslie Vanderburgh; Stuart Bell
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

View more
  14 in total

1.  Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006.

Authors:  Susanna D Mitro; Ami R Zota
Journal:  Reprod Toxicol       Date:  2015-06-03       Impact factor: 3.143

2.  Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.

Authors:  Mark A Hayden; Zehra Ordulu; C Scott Gallagher; Bradley J Quade; Raymond M Anchan; Nia Robinson Middleton; Serene S Srouji; Elizabeth A Stewart; Cynthia C Morton
Journal:  Cancer Genet       Date:  2018-02-19

3.  Enodthelin 1 is elevated in plasma and explants from patients having uterine leiomyomas.

Authors:  Kedra Wallace; Krystal Chatman; Justin Porter; Jeremy Scott; Venessia Johnson; Janae Moseley; Babbette LaMarca
Journal:  Reprod Sci       Date:  2014-09       Impact factor: 3.060

Review 4.  Hearing the Silenced Voices of Underserved Women: The Role of Qualitative Research in Gynecologic and Reproductive Care.

Authors:  Angela K Lawson; Erica E Marsh
Journal:  Obstet Gynecol Clin North Am       Date:  2017-03       Impact factor: 2.844

Review 5.  Epigenomic and enhancer dysregulation in uterine leiomyomas.

Authors:  Oliwia W Mlodawska; Priyanka Saini; J Brandon Parker; Jian-Jun Wei; Serdar E Bulun; Melissa A Simon; Debabrata Chakravarti
Journal:  Hum Reprod Update       Date:  2022-06-30       Impact factor: 17.179

6.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population.

Authors:  Michael J Bray; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Maturitas       Date:  2018-05-11       Impact factor: 4.342

Review 7.  The health disparities of uterine fibroid tumors for African American women: a public health issue.

Authors:  Heba M Eltoukhi; Monica N Modi; Meredith Weston; Alicia Y Armstrong; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2013-08-11       Impact factor: 8.661

8.  Transethnic and race-stratified genome-wide association study of fibroid characteristics in African American and European American women.

Authors:  Michael J Bray; Melissa F Wellons; Sarah H Jones; Eric S Torstenson; Todd L Edwards; Digna R Velez Edwards
Journal:  Fertil Steril       Date:  2018-09       Impact factor: 7.490

Review 9.  Medical Therapies for Uterine Fibroids - A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.

Authors:  Kurinchi S Gurusamy; Jessica Vaughan; Ian S Fraser; Lawrence M J Best; Toby Richards
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

Review 10.  The future for genetic studies in reproduction.

Authors:  G W Montgomery; K T Zondervan; D R Nyholt
Journal:  Mol Hum Reprod       Date:  2013-08-26       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.